CytoDyn Inc., a clinical-stage oncology company, announced it will hold an investor webcast on April 30, 2026, to provide updates on its cancer drug leronlimab. The webcast will cover recent scientific, clinical, operational, and financial developments, as well as the company's priorities and milestones for 2026. CEO Dr. Jacob P. Lalezari and other executives will present and answer questions. This event highlights CytoDyn's ongoing efforts to advance leronlimab, which targets the CCR5 receptor and shows potential in treating metastatic triple-negative breast cancer and colorectal cancer.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
DMG Blockchain Solutions announced two strategic investments: one in MeetAmi Innovations, a Canadian fintech offering digital asset wealth management platforms, and another in Atomic47 Labs, an AI company focused on secure, sovereign AI infrastructur...
Gnosis (GNO) surged 13% in 24 hours, closing in on overtaking BONK by market capitalization to reach the 100th largest token spot. GNO's market cap stands at $303.88 million versus BONK's $330.07 million, requiring a price rise to about $125.48 for t...
Broadridge's Tokenization Pulse Survey shows 84% of firms view tokenization as strategically important, with 68% expecting it to reshape markets within 3-5 years. Most firms plan to integrate tokenization into existing infrastructure rather than buil...
Standard Chartered has partnered with Broadcom to modernize its global banking infrastructure by adopting a secure, resilient private cloud using VMware Cloud Foundation. This upgrade supports critical banking services across 54 markets with enhanced...
